Literature DB >> 9611899

The use of societal criteria in priority setting for health technology assessment in The Netherlands. Initial experiences and future challenges.

W J Oortwijn1, H Vondeling, L Bouter.   

Abstract

Priority setting for the evaluation of health technologies in the Netherlands is exclusively based on the scientific merits of individual research proposals. This process has not resulted in satisfactory allocation of resources. Therefore, societal criteria for setting priorities for health technology assessment have been proposed as an adjunct to scientific criteria. These societal criteria include the burden of disease, uncertainty about the (cost-)effectiveness of the intervention at issue, the potential benefits of the research project, and its potential impact on health care. To realize the full potential of this model for priority setting, a number of methodological issues need to be addressed. Joint efforts of researchers and policy makers in this field are necessary for future progress.

Keywords:  Health Care and Public Health

Mesh:

Year:  1998        PMID: 9611899     DOI: 10.1017/s0266462300012216

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  3 in total

1.  A checklist for health research priority setting: nine common themes of good practice.

Authors:  Roderik F Viergever; Sylvie Olifson; Abdul Ghaffar; Robert F Terry
Journal:  Health Res Policy Syst       Date:  2010-12-15

2.  The health systems' priority setting criteria for selecting health technologies: A systematic review of the current evidence.

Authors:  Mohammadreza Mobinizadeh; Pouran Raeissi; Amir Ashkan Nasiripour; Alireza Olyaeemanesh; Seyed Jamaleddin Tabibi
Journal:  Med J Islam Repub Iran       Date:  2016-02-16

3.  Ethical and Social Values for Paediatric Health Technology Assessment and Drug Policy.

Authors:  Avram E Denburg; Mita Giacomini; Wendy Ungar; Julia Abelson
Journal:  Int J Health Policy Manag       Date:  2022-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.